188 related articles for article (PubMed ID: 37933268)
1. Curcumin's Dose-Dependent Attenuation of Gastric Cancer Cell Progression Via the PI3K Pathway Blockade.
Xi G; Dong Q; Yang B; Jiao D; Khan S
Dose Response; 2023; 21(4):15593258231203585. PubMed ID: 37933268
[No Abstract] [Full Text] [Related]
2. Curcumin inhibits the growth and invasion of gastric cancer by regulating long noncoding RNA AC022424.2.
Wang BS; Zhang CL; Cui X; Li Q; Yang L; He ZY; Yang Z; Zeng MM; Cao N
World J Gastrointest Oncol; 2024 Apr; 16(4):1437-1452. PubMed ID: 38660661
[TBL] [Abstract][Full Text] [Related]
3. The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K/AKT pathway.
Hamzehzadeh L; Atkin SL; Majeed M; Butler AE; Sahebkar A
J Cell Physiol; 2018 Oct; 233(10):6530-6537. PubMed ID: 29693253
[TBL] [Abstract][Full Text] [Related]
4. Curcumin suppresses the progression of laryngeal squamous cell carcinoma through the upregulation of miR-145 and inhibition of the PI3K/Akt/mTOR pathway.
Zhu X; Zhu R
Onco Targets Ther; 2018; 11():3521-3531. PubMed ID: 29950857
[TBL] [Abstract][Full Text] [Related]
5. Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway.
Wang N; Feng T; Liu X; Liu Q
Acta Pharm; 2020 Sep; 70(3):399-409. PubMed ID: 32074070
[TBL] [Abstract][Full Text] [Related]
6. Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management.
Moon DO
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474160
[TBL] [Abstract][Full Text] [Related]
7.
Feng L; Lu WH; Li QY; Zhang HY; Xu LR; Zang WQ; Guo WT; Li YF; Zheng WJ; Geng YX; Li Q; Liu YH
Am J Chin Med; 2023; 51(5):1189-1209. PubMed ID: 37314412
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnological synergy of mangiferin and curcumin in modulating PI3K/Akt/mTOR pathway: a novel front in ovarian cancer precision therapeutics.
Alharbi HM; Alqahtani T; Alamri AH; Kumarasamy V; Subramaniyan V; Babu KS
Front Pharmacol; 2023; 14():1276209. PubMed ID: 38239204
[No Abstract] [Full Text] [Related]
9. Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway.
Teng YJ; Deng Z; Ouyang ZG; Zhou Q; Mei S; Fan XX; Wu YR; Long HP; Fang LY; Yin DL; Zhang BY; Guo YM; Zhu WH; Huang Z; Zheng P; Ning DM; Tian XF
World J Gastrointest Oncol; 2022 Apr; 14(4):872-886. PubMed ID: 35582102
[TBL] [Abstract][Full Text] [Related]
10. Curcumin downregulates the PI3K-AKT-mTOR pathway and inhibits growth and progression in head and neck cancer cells.
Borges GA; Elias ST; Amorim B; de Lima CL; Coletta RD; Castilho RM; Squarize CH; Guerra ENS
Phytother Res; 2020 Dec; 34(12):3311-3324. PubMed ID: 32628350
[TBL] [Abstract][Full Text] [Related]
11. Curcumin inhibits superoxide dismutase-induced epithelial-to-mesenchymal transition via the PI3K/Akt/NF-κB pathway in pancreatic cancer cells.
Li W; Jiang Z; Xiao X; Wang Z; Wu Z; Ma Q; Cao L
Int J Oncol; 2018 May; 52(5):1593-1602. PubMed ID: 29512729
[TBL] [Abstract][Full Text] [Related]
12. The Influence of Curcumin on the Downregulation of MYC, Insulin and IGF-1 Receptors: A possible Mechanism Underlying the Anti-Growth and Anti-Migration in Chemoresistant Colorectal Cancer Cells.
Hosseini SA; Zand H; Cheraghpour M
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30987250
[No Abstract] [Full Text] [Related]
13. Curcumin Regulates Cancer Progression: Focus on ncRNAs and Molecular Signaling Pathways.
Wang H; Zhang K; Liu J; Yang J; Tian Y; Yang C; Li Y; Shao M; Su W; Song N
Front Oncol; 2021; 11():660712. PubMed ID: 33912467
[TBL] [Abstract][Full Text] [Related]
14. Curcumin's Beneficial Effects on Neuroblastoma: Mechanisms, Challenges, and Potential Solutions.
Zhai K; Brockmüller A; Kubatka P; Shakibaei M; Büsselberg D
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33105719
[TBL] [Abstract][Full Text] [Related]
15. Curcumin regulates proliferation, autophagy, and apoptosis in gastric cancer cells by affecting PI3K and P53 signaling.
Fu H; Wang C; Yang D; Wei Z; Xu J; Hu Z; Zhang Y; Wang W; Yan R; Cai Q
J Cell Physiol; 2018 Jun; 233(6):4634-4642. PubMed ID: 28926094
[TBL] [Abstract][Full Text] [Related]
16. Reduced Caudal Type Homeobox 2 (CDX2) Promoter Methylation Is Associated with Curcumin's Suppressive Effects on Epithelial-Mesenchymal Transition in Colorectal Cancer Cells.
Chen T; Yang C; Xi Z; Chen F; Li H
Med Sci Monit; 2020 Sep; 26():e926443. PubMed ID: 32893845
[TBL] [Abstract][Full Text] [Related]
17. The differential susceptibilities of MCF-7 and MDA-MB-231 cells to the cytotoxic effects of curcumin are associated with the PI3K/Akt-SKP2-Cip/Kips pathway.
Jia T; Zhang L; Duan Y; Zhang M; Wang G; Zhang J; Zhao Z
Cancer Cell Int; 2014; 14(1):126. PubMed ID: 25530715
[TBL] [Abstract][Full Text] [Related]
18. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
19. Curcumin (CUMINUP60®) mitigates exercise fatigue through regulating PI3K/Akt/AMPK/mTOR pathway in mice.
Hu M; Han M; Zhang H; Li Z; Xu K; Kang H; Zong J; Zhao F; Liu Y; Liu W
Aging (Albany NY); 2023 Mar; 15(6):2308-2320. PubMed ID: 36988546
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.
Jurenka JS
Altern Med Rev; 2009 Jun; 14(2):141-53. PubMed ID: 19594223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]